The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for PB Yu


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.EBI
Massachusetts Institute of Technology
Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.EBI
Harvard Medical School
Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors.EBI
National Center For Advancing Translational Sciences
GLP-1 receptor agonist and use thereofBDB
Ildong Pharmaceutical
Purine derivatives as CB2 receptor agonistsBDB
Hoffmann-La Roche
5-Amidinoindoles as dual inhibitors of coagulation factors IXa and Xa.BDB
Bristol-Myers Squibb